noriday
pfizer new zealand limited - norethisterone 0.35mg; ; - tablet - 0.35 mg - active: norethisterone 0.35mg excipient: lactose monohydrate magnesium stearate maize starch povidone - noriday is indicated for oral contraception in women for whom oestrogens may not be appropriate.
rimactane 300mg milligram capsule
sandoz gmbh - rifampicin - capsule - 300mg milligram
rimactane 150mg milligram capsule
sandoz gmbh - rifampicin - capsule - 150mg milligram
rimactazid 300/150mg milligram coated tablets
sandoz gmbh - rifampicin isoniazid - coated tablets - 300/150mg milligram
dogmatil capsule 50 mg
sanofi-aventis singapore pte. ltd. - sulpiride - capsule - 50 mg
dogmatil tablet 200 mg
sanofi-aventis singapore pte. ltd. - sulpiride - tablet - 200 mg
baclofen sintetica
boucher & muir (new zealand) limited t/a bnm group - baclofen 0.5 mg/ml - solution for infusion - 0.5 mg/ml - active: baclofen 0.5 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.
baclofen sintetica
boucher & muir (new zealand) limited t/a bnm group - baclofen 2 mg/ml - solution for infusion - 2 mg/ml - active: baclofen 2 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.
baclofen sintetica
boucher & muir (new zealand) limited t/a bnm group - baclofen 0.05 mg/ml - solution for injection - 0.05 mg/ml - active: baclofen 0.05 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.
bacthecal baclofen 10 mg/5 ml intrathecal solution for injection ampoule
medsurge pharma pty ltd - baclofen, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.